Abstract
Alterations in cholesterol homeostasis are associated with Alzheimer’s disease (AD). The role played by specific fractions of serum lipoproteins in modifying the risk of AD, and the interaction with APOE genotype has not yet been investigated. We studied serum lipoprotein profiles using a gradient-density ultracentrifugation method in a cohort of lateonset sporadic AD patients without cerebrovascular lesions and in healthy elderly subjects.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bonarek M, Barberger-Gateau P, Letenneur L, Deschamps V, Iron A, Dubroca B, Dartigues JF (2000) Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepidemiology 19: 141–148
Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A (2006) APOE genotype and cholesterol levels in Lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry 14: 1022–1031
Chung BH, Wilkinson T, Geer JC, Segrest JP (1980) Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 21: 284–291
Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT (1986) Single vertical spin density gradient ultracentrifugation. In: Segrest JP, Albers JJ (eds) Methods in enzymology, plasma lipoproteins: preparation, structure, and molecular biology. Academic Press, San Diego 181–209
De la Torre JC (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3: 184–190
Dietschy JM, Turley SD (2004) Cholesterol metabolism in the central nervous system during early development and in mature animal. J Lipid Res 45: 1375–1393
Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, Hendrie H (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: a population-based study of African Americans. Neurology 54: 240–242
Hay den KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators (2006) Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20: 93–100
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545–548
Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer’s disease-epidemiological evidence. Acta Neurol Scand 114: 50–57
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5: 735–741
Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE (1998) Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain abeta 1–42 levels. Biochem Biophys Res Commun 252: 711–715
Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease. Dement Geriat Cogn Disord 12: 138–145
Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65: 545–551
McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34: 939–944
Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoprotein E epsilon allele, and Alzheimer’s disease. Neuroepidemiology 17: 14–20
Ohm TG, Meske V (2006) Cholesterol, statins and tau. Acta Neurol Scand 114: 93–101
Panza F, D’Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51: 275–292
Romas SN, Tang MX, Berglund L, Mayeux R (1999) APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 53: 517–521
Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC (2002) Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport 13: 455–459
Shobab LA, Hsiung G-YR, Feldman HH (2005) Cholesterol in Alzheimer’s disease. Lancet Neurol 4: 841–852
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. PNAS 95: 6460–6464
Stampfer MJ (2006) Cardiovascular disease and Alzheimer’s disease: common links. J Int Med 260: 211–223
Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel PD, Tocco M, D’Agostino RB, Wolf PA (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Int Med 163: 1053–1057
Wahlund LO, Barkhof F, Fakezas F, Bronge L, Augustin M, Sjoegren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) On behalf of the European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32: 1318–1322
Wolozin B, Manger J, Bryant R, Cordy J, Green RC, McKee A (2006) Re-assessing the relationship between cholesterol, statins and Alzheimer’s disease. Acta Neurol Scand 114 Suppl 185: 63–70
Zlokovic VB (2005) Neurovascular mechanisms of Alzheimer’s disease neurodegeneration. Trends Neurosci 28: 202–208
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag
About this paper
Cite this paper
Cagnin, A. et al. (2007). Serum lipoprotein profile and APOE genotype in Alzheimer’s disease. In: Gerlach, M., Deckert, J., Double, K., Koutsilieri, E. (eds) Neuropsychiatric Disorders An Integrative Approach. Journal of Neural Transmission. Supplementa, vol 72. Springer, Vienna. https://doi.org/10.1007/978-3-211-73574-9_22
Download citation
DOI: https://doi.org/10.1007/978-3-211-73574-9_22
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-73573-2
Online ISBN: 978-3-211-73574-9
eBook Packages: MedicineMedicine (R0)